GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Green Life Science Co Ltd (XKRX:114450) » Definitions » Debt-to-Equity

Green Life Science Co (XKRX:114450) Debt-to-Equity : 0.15 (As of Dec. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Green Life Science Co Debt-to-Equity?

Green Life Science Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩4,841 Mil. Green Life Science Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩531 Mil. Green Life Science Co's Total Stockholders Equity for the quarter that ended in Dec. 2024 was ₩35,748 Mil. Green Life Science Co's debt to equity for the quarter that ended in Dec. 2024 was 0.15.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Green Life Science Co's Debt-to-Equity or its related term are showing as below:

XKRX:114450' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.07   Med: 0.12   Max: 0.15
Current: 0.15

During the past 13 years, the highest Debt-to-Equity Ratio of Green Life Science Co was 0.15. The lowest was 0.07. And the median was 0.12.

XKRX:114450's Debt-to-Equity is ranked better than
65.04% of 818 companies
in the Drug Manufacturers industry
Industry Median: 0.27 vs XKRX:114450: 0.15

Green Life Science Co Debt-to-Equity Historical Data

The historical data trend for Green Life Science Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Green Life Science Co Debt-to-Equity Chart

Green Life Science Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.14 0.13 0.14 0.15

Green Life Science Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.14 0.13 0.14 0.15

Competitive Comparison of Green Life Science Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Green Life Science Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Green Life Science Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Green Life Science Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Green Life Science Co's Debt-to-Equity falls into.


;
;

Green Life Science Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Green Life Science Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Green Life Science Co's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Green Life Science Co  (XKRX:114450) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Green Life Science Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Green Life Science Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Green Life Science Co Business Description

Traded in Other Exchanges
N/A
Address
84, Yeosusandan 2-ro, Jeollanam-do, Yeosu-si, KOR, 555-280
Green Life Science Co Ltd Formerly KPX Lifescience Co Ltd manufactures and markets active pharmaceutical ingredients and pharmaceutical intermediates. The company exports all its products to global pharmaceutical firms exclusively. Its products include Dexibuprofen, Quetiapine hemifumarate, Venlafaxine free base and Triazolinone among others.

Green Life Science Co Headlines

No Headlines